Cargando…

Comparison of the Journey II bicruciate stabilised (JII-BCS) and GENESIS II total knee arthroplasty for functional ability and motor impairment: the CAPAbility, blinded, randomised controlled trial

OBJECTIVES: To determine if a newer design of total knee replacement (TKR) (Journey II BCS) produces superior patient-reported outcomes scores and biomechanical outcomes than the older, more established design (Genesis II). SETTING: Patients were recruited from an NHS University Hospital between Jul...

Descripción completa

Detalles Bibliográficos
Autores principales: McNamara, Iain, Pomeroy, Valerie, Clark, Allan B, Creelman, Graham, Whitehouse, Celia, Wells, J, Harry, B, Smith, Toby O, High, Juliet, Swart, Ann Marie, Clarke, Celia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815016/
https://www.ncbi.nlm.nih.gov/pubmed/36599639
http://dx.doi.org/10.1136/bmjopen-2022-061648
_version_ 1784864263104364544
author McNamara, Iain
Pomeroy, Valerie
Clark, Allan B
Creelman, Graham
Whitehouse, Celia
Wells, J
Harry, B
Smith, Toby O
High, Juliet
Swart, Ann Marie
Clarke, Celia
author_facet McNamara, Iain
Pomeroy, Valerie
Clark, Allan B
Creelman, Graham
Whitehouse, Celia
Wells, J
Harry, B
Smith, Toby O
High, Juliet
Swart, Ann Marie
Clarke, Celia
author_sort McNamara, Iain
collection PubMed
description OBJECTIVES: To determine if a newer design of total knee replacement (TKR) (Journey II BCS) produces superior patient-reported outcomes scores and biomechanical outcomes than the older, more established design (Genesis II). SETTING: Patients were recruited from an NHS University Hospital between July 2018 and October 2019 with surgery at two sites. Biomechanical and functional capacity measurements were at a University Movement and Exercise Laboratory. PARTICIPANTS: 80 participants undergoing single-stage TKR. INTERVENTIONS: Patients were randomised to receive either the Journey II BCS (JII-BCS) or Genesis II TKR. PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcome was the Oxford Knee Score (OKS), at 6 months. Secondary outcomes were: OKS Activity and Participation Questionnaire, EQ-5D-5L and UCLA Activity scores, Timed Up and Go Test, 6 min walk test, lower limb kinematics and lower limb muscle activity during walking and balance. RESULTS: This study found no difference in the OKS between groups. The OKS scores for the JII-BCS and Genesis II groups were mean (SD) 42.97 (5.21) and 43.13 (5.20) respectively, adjusted effect size 0.35 (-2.01,2.71) p=0.771 In secondary outcome measures, the Genesis II group demonstrated a significantly greater walking range-of-movement (50.62 (7.33) vs 46.07 (7.71) degrees, adjusted effect size, 3.14 (0.61,5.68) p=0.02) and higher peak knee flexion angular velocity during walking (mean (SD) 307.69 (38.96) vs 330.38 (41.40) degrees/second, adjusted effect size was 21.75 (4.54,38.96), p=0.01) and better postural control (smaller resultant centre of path length) during quiet standing than the JII-BCS group (mean (SD) 158.14 (65.40) vs 235.48 (176.94) mm, adjusted effect size, 59.91 (–105.98, –13.85) p=0.01.). CONCLUSIONS: In this study population, the findings do not support the hypothesis that the Journey II BCS produces a better outcome than the Genesis II for the primary outcome of the OKS at 6 months after surgery. TRIAL REGISTRATION NUMBER: ISRCTN32315753.
format Online
Article
Text
id pubmed-9815016
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-98150162023-01-06 Comparison of the Journey II bicruciate stabilised (JII-BCS) and GENESIS II total knee arthroplasty for functional ability and motor impairment: the CAPAbility, blinded, randomised controlled trial McNamara, Iain Pomeroy, Valerie Clark, Allan B Creelman, Graham Whitehouse, Celia Wells, J Harry, B Smith, Toby O High, Juliet Swart, Ann Marie Clarke, Celia BMJ Open Evidence Based Practice OBJECTIVES: To determine if a newer design of total knee replacement (TKR) (Journey II BCS) produces superior patient-reported outcomes scores and biomechanical outcomes than the older, more established design (Genesis II). SETTING: Patients were recruited from an NHS University Hospital between July 2018 and October 2019 with surgery at two sites. Biomechanical and functional capacity measurements were at a University Movement and Exercise Laboratory. PARTICIPANTS: 80 participants undergoing single-stage TKR. INTERVENTIONS: Patients were randomised to receive either the Journey II BCS (JII-BCS) or Genesis II TKR. PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcome was the Oxford Knee Score (OKS), at 6 months. Secondary outcomes were: OKS Activity and Participation Questionnaire, EQ-5D-5L and UCLA Activity scores, Timed Up and Go Test, 6 min walk test, lower limb kinematics and lower limb muscle activity during walking and balance. RESULTS: This study found no difference in the OKS between groups. The OKS scores for the JII-BCS and Genesis II groups were mean (SD) 42.97 (5.21) and 43.13 (5.20) respectively, adjusted effect size 0.35 (-2.01,2.71) p=0.771 In secondary outcome measures, the Genesis II group demonstrated a significantly greater walking range-of-movement (50.62 (7.33) vs 46.07 (7.71) degrees, adjusted effect size, 3.14 (0.61,5.68) p=0.02) and higher peak knee flexion angular velocity during walking (mean (SD) 307.69 (38.96) vs 330.38 (41.40) degrees/second, adjusted effect size was 21.75 (4.54,38.96), p=0.01) and better postural control (smaller resultant centre of path length) during quiet standing than the JII-BCS group (mean (SD) 158.14 (65.40) vs 235.48 (176.94) mm, adjusted effect size, 59.91 (–105.98, –13.85) p=0.01.). CONCLUSIONS: In this study population, the findings do not support the hypothesis that the Journey II BCS produces a better outcome than the Genesis II for the primary outcome of the OKS at 6 months after surgery. TRIAL REGISTRATION NUMBER: ISRCTN32315753. BMJ Publishing Group 2023-01-04 /pmc/articles/PMC9815016/ /pubmed/36599639 http://dx.doi.org/10.1136/bmjopen-2022-061648 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Evidence Based Practice
McNamara, Iain
Pomeroy, Valerie
Clark, Allan B
Creelman, Graham
Whitehouse, Celia
Wells, J
Harry, B
Smith, Toby O
High, Juliet
Swart, Ann Marie
Clarke, Celia
Comparison of the Journey II bicruciate stabilised (JII-BCS) and GENESIS II total knee arthroplasty for functional ability and motor impairment: the CAPAbility, blinded, randomised controlled trial
title Comparison of the Journey II bicruciate stabilised (JII-BCS) and GENESIS II total knee arthroplasty for functional ability and motor impairment: the CAPAbility, blinded, randomised controlled trial
title_full Comparison of the Journey II bicruciate stabilised (JII-BCS) and GENESIS II total knee arthroplasty for functional ability and motor impairment: the CAPAbility, blinded, randomised controlled trial
title_fullStr Comparison of the Journey II bicruciate stabilised (JII-BCS) and GENESIS II total knee arthroplasty for functional ability and motor impairment: the CAPAbility, blinded, randomised controlled trial
title_full_unstemmed Comparison of the Journey II bicruciate stabilised (JII-BCS) and GENESIS II total knee arthroplasty for functional ability and motor impairment: the CAPAbility, blinded, randomised controlled trial
title_short Comparison of the Journey II bicruciate stabilised (JII-BCS) and GENESIS II total knee arthroplasty for functional ability and motor impairment: the CAPAbility, blinded, randomised controlled trial
title_sort comparison of the journey ii bicruciate stabilised (jii-bcs) and genesis ii total knee arthroplasty for functional ability and motor impairment: the capability, blinded, randomised controlled trial
topic Evidence Based Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815016/
https://www.ncbi.nlm.nih.gov/pubmed/36599639
http://dx.doi.org/10.1136/bmjopen-2022-061648
work_keys_str_mv AT mcnamaraiain comparisonofthejourneyiibicruciatestabilisedjiibcsandgenesisiitotalkneearthroplastyforfunctionalabilityandmotorimpairmentthecapabilityblindedrandomisedcontrolledtrial
AT pomeroyvalerie comparisonofthejourneyiibicruciatestabilisedjiibcsandgenesisiitotalkneearthroplastyforfunctionalabilityandmotorimpairmentthecapabilityblindedrandomisedcontrolledtrial
AT clarkallanb comparisonofthejourneyiibicruciatestabilisedjiibcsandgenesisiitotalkneearthroplastyforfunctionalabilityandmotorimpairmentthecapabilityblindedrandomisedcontrolledtrial
AT creelmangraham comparisonofthejourneyiibicruciatestabilisedjiibcsandgenesisiitotalkneearthroplastyforfunctionalabilityandmotorimpairmentthecapabilityblindedrandomisedcontrolledtrial
AT whitehousecelia comparisonofthejourneyiibicruciatestabilisedjiibcsandgenesisiitotalkneearthroplastyforfunctionalabilityandmotorimpairmentthecapabilityblindedrandomisedcontrolledtrial
AT wellsj comparisonofthejourneyiibicruciatestabilisedjiibcsandgenesisiitotalkneearthroplastyforfunctionalabilityandmotorimpairmentthecapabilityblindedrandomisedcontrolledtrial
AT harryb comparisonofthejourneyiibicruciatestabilisedjiibcsandgenesisiitotalkneearthroplastyforfunctionalabilityandmotorimpairmentthecapabilityblindedrandomisedcontrolledtrial
AT smithtobyo comparisonofthejourneyiibicruciatestabilisedjiibcsandgenesisiitotalkneearthroplastyforfunctionalabilityandmotorimpairmentthecapabilityblindedrandomisedcontrolledtrial
AT highjuliet comparisonofthejourneyiibicruciatestabilisedjiibcsandgenesisiitotalkneearthroplastyforfunctionalabilityandmotorimpairmentthecapabilityblindedrandomisedcontrolledtrial
AT swartannmarie comparisonofthejourneyiibicruciatestabilisedjiibcsandgenesisiitotalkneearthroplastyforfunctionalabilityandmotorimpairmentthecapabilityblindedrandomisedcontrolledtrial
AT clarkecelia comparisonofthejourneyiibicruciatestabilisedjiibcsandgenesisiitotalkneearthroplastyforfunctionalabilityandmotorimpairmentthecapabilityblindedrandomisedcontrolledtrial